SETD2 and H3K36me3 are closely correlated with the development and progression of hepatocellular carcinoma, but there are different ideas about whether SETD2 expression and H3K36me3 promote or inhibit hepatocellular carcinoma progression 13-15. Here, SETD2 is linked to hepatocellular carcinoma.